TheEdgeResearch
Home / Stocks / BIMI

BIMI International Medical Inc. (BIMI)

OTC Healthcare Medical - Distribution
$0.00 ▲ +0.00%
Market Cap
$1,396
Sector
Healthcare
Industry
Medical - Distribution
Beta
-0.56
52-Wk Range
0.0001-0.0002
CEO
Tiewei Song
Country
US
Currency
USD

BIMI International Medical Inc. operates in the Medical - Distribution industry of the Healthcare sector, headquartered in New York, NY, US. The stock last traded at $0.00, up 0.00% on the session, giving a market capitalisation of $1,396. On trailing twelve-month figures it carries a trailing P/E of -0.00, a net margin of -189.3%. Its beta of -0.56 implies it has historically moved less than the broad market.

Valuation & profitability (TTM)
P/E
-0.00
Price / Sales
0.00
Price / Book
0.00
EV / EBITDA
-0.17
Gross margin
16.5%
Operating margin
-129.7%
Net margin
-189.3%
Return on equity
Debt / equity
1.35
Current ratio
0.92
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
Other OTC
Employees
296
IPO date
2006-10-18
Headquarters
New York, NY, US
About BIMI International Medical Inc.

BIMI International Medical Inc., headquartered in Chongqing, China, is an enterprise engaged in a diverse array of healthcare operations. The company, which was established in 2000 and adopted its current name in June 2021 (formerly BOQI International Medical Inc.), focuses on the supply and sale of medical devices, pharmaceuticals, and other health-related products. Its business activities are structured across four main divisions: wholesale pharmaceuticals, wholesale medical devices, medical services, and retail pharmacies. For its wholesale segment, BIMI distributes a wide range of specialized medical equipment, including Stryker spinal products, Olympus endoscopes, various imported imaging devices, and diagnostic imaging systems. These products are supplied to clients such as drugstores, private clinics, pharmaceutical dealers, and hospitals, particularly within China's Southwest region. The company also facilitates the distribution of a broad spectrum of pharmaceutical products, comprising generic medications, traditional Chinese herbal remedies, biochemical drugs, essential raw ingredients for pharmaceuticals, antibiotics, cardiovascular treatments, and anti-obesity medicines. Through its "Lijiantang Pharmacy" brand, BIMI operates a network of directly-owned retail outlets. These pharmacies offer consumers an extensive selection of items, including prescription and over-the-counter drugs, nutritional supplements, health foods, sundry goods, traditional Chinese medicines, personal and family care products, and medical devices. Beyond product sales, BIMI also delivers medical services within hospital environments and undertakes IT research and development initiatives.

Comparable companies

BIMI International Medical Inc. is most often compared with the following Healthcare names:

ADYXBGMDCFRXQDMKPQEFTRFSPMGRPIIMVIFPCYSUTRS
More research on BIMI
BIMI technical analysis BIMI TheEdge Score Compare against peers
Open full interactive analysis & DCF →